<unk>  is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is FDA approved for the treatment of HIV-1 infection in adult patients with no prior antiretroviral treatment history, in combination with other antiretroviral agents.   Common adverse reactions include nausea, dizziness, headache, fatigue, diarrhea, abdominal pain, and abnormal dreams.
Doravirine
Saquinavir
Entecavir
Fosamprenavir
Abacavir
Tipranavir
Letermovir
Darunavir